CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul. By Jennifer ... The Korea-Seoul Life Science Fund (KSLSF) is a cross-border venture capital fund that invests in innovative life sciences companies. The Korea Seoul Life Science Fund, which numbers conglomerate Hanwha among its backers, has invested $2.6m in biopharma company CrystalGenomics.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.